However, a study demonstrated that E2F4 expression in breast cancer tissues was lower than that in normal tissues and was unrelated to the tumor staging of patients with breast cancer, which suggests that E2F4 can also act as an anti-oncogene13. Here, E2F4 is linked to breast carcinoma.